The Joint Corp. logo
The Joint Corp. JYNT
$ 8.35 -0.12%
report update icon

Quarterly report 2026-Q1
added 06-06-2026

The Joint Corp. Financial Ratios 2025-2011 | JYNT

Brief overview of The Joint Corp.'s market valuation

The comparison uses the five latest available annual observations between 2020 and 2025.

Market valuation is represented by P/E 126.59x (median 126.59x), EV/EBITDA 60.15x (median 60.15x), P/S 8.27x (median 8.41x). The multiple basket looks neutral against its history, differing from median levels by roughly 0%.

Current earnings relative to valuation equal about 0.8% on the 1/P/E measure. This is a valuation reference, not an expected payout.

Returns on assets and capital are represented by ROE 6.6%, ROA 1.6%, ROCE 4.9%. Profitability remains low. Market valuation has limited fundamental support until resource returns improve.

The cash cycle accelerated by 85.6 days to -150.8 days. Less capital is tied up in operations.

What the ratios show

The Joint Corp.'s profile looks neutral, with price and fundamental efficiency broadly aligned.

Annual Financial Ratios The Joint Corp.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

126.6 7001.4 -11.0 383.5 102.3 34.6 71.5 440.7 -20.7 -2.9 -5.0 -11.6 - - -

P/S

8.3 8.4 9.6 2.4 9.7 7.8 4.9 3.5 2.7 2.2 3.2 4.9 - - -

EPS

0.1 - -0.8 -0.4 0.5 0.9 0.2 0.0 -0.3 -1.2 -0.9 -0.6 0.0 - -

EV (Enterprise Value)

148 M 161 M 166 M 292 M 811 M 480 M 267 M 124 M 75.6 M 51.6 M 39.7 M 27.2 M 7.47 M 10.2 M -

EBITDA per Share

0.16 0.37 0.65 0.33 0.7 0.584 0.393 0.172 -0.0558 -0.704 -0.801 -0.26 - - -

EV/EBITDA

60.2 29.1 17.3 61.3 70.8 53.8 42.2 44.1 -87.5 -4.7 -3.4 -10.1 - - -

PEG

-17.67 503.24 -0.23 -7.24 -1.68 0.12 0.06 -4.1 0.26 -0.08 -0.09 0.0 - - -

P/B

8.3 6.0 4.9 7.4 25.5 22.0 41.6 47.2 13.8 6.4 2.1 2.2 - - -

P/CF

68.2 13.1 8.3 29.3 55.9 65.2 70.8 27.5 -231.6 -3.5 -3.7 -21.9 - - -

ROE %

6.58 0.09 -44.62 1.92 24.98 63.45 58.10 10.72 -66.86 -219.10 -42.54 -19.40 - - -

ROA %

1.63 0.02 -12.66 0.67 8.69 20.03 7.60 1.08 -19.37 -88.97 -26.37 -10.61 - - -

ROCE %

4.93 3.92 4.02 -5.80 20.23 11.56 11.71 5.40 -23.08 -102.78 -36.01 -6.70 - - -

Current Ratio

1.3 1.3 1.4 1.5 1.5 1.3 1.0 1.3 1.3 1.0 2.5 5.5 - - -

DSO

65.4 64.1 71.4 11.0 12.7 11.5 20.9 15.7 19.0 19.6 23.1 57.9 - - -

DPO

216.2 172.2 271.2 74.0 77.8 87.6 100.1 106.1 117.8 131.0 258.5 206.6 - - -

Operating Cycle

65.4 64.1 71.3 11.0 12.7 11.5 20.9 15.7 19.0 19.6 23.1 57.9 - - -

Cash Conversion Cycle

-150.8 -108.1 -199.8 -63.1 -65.1 -76.1 -79.2 -90.5 -98.8 -111.3 -235.4 -148.7 - - -

All numbers in USD currency

Quarterly Financial Ratios The Joint Corp.

2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.09 0.06 0.01 0.06 -0.21 -0.24 0.06 -0.05 -0.02 0.16 - 0.03 -0.06 -0.01 - 0.13 0.19 0.16 - 0.11 0.01 0.06 - 0.04 0.03 0.07 - -0.02 -0.01 0.01 - -0.03 -0.08 -0.14 - -0.21 -0.26 -0.28 - -0.17 -0.19 -0.2 - -0.04 -0.03 -0.03 - 0.01 - - - - - - - - - -

EBITDA per Share

0.09 0.09 -0.02 -0.02 -0.13 -0.13 0.17 0.1 0.13 0.11 - 0.17 0.01 0.1 - 0.21 0.24 0.22 - 0.17 0.07 0.1 - 0.09 0.06 0.1 - 0.01 0.03 0.04 - - -0.04 -0.09 - -0.15 -0.2 -0.23 - -0.17 -0.16 -0.19 - -0.05 -0.03 -0.02 - 0.04 - - - - - - - - - -

ROE %

16.81 -7.07 -26.34 -23.13 -29.40 -14.83 7.24 5.18 4.33 4.54 -2.02 4.51 12.78 25.44 26.13 33.94 27.97 22.06 12.30 23.08 23.35 39.45 35.52 6.99 -10.78 -23.21 -39.86 -77.29 -137.38 -275.76 -271.41 -309.34 -319.01 -281.29 -135.93 -143.94 -114.98 -77.09 -26.19 -27.49 -20.33 -12.18 -2.97 -6.45 -0.86 -0.82 - -3.48 - - - - - - - - - -

ROA %

4.81 -1.41 -7.00 -6.03 -7.96 -4.31 2.40 1.85 1.58 1.66 -0.69 1.71 4.59 9.05 9.29 11.73 9.51 7.31 3.85 5.26 3.88 5.89 4.65 3.76 2.13 0.94 -1.24 -3.58 -8.24 -17.60 -17.47 -32.87 -49.65 -64.78 -55.19 -60.16 -50.32 -36.90 -16.23 -16.95 -12.45 -7.34 -1.63 -1.19 -0.47 -0.45 - 0.44 - - - - - - - - - -

ROCE %

-1.52 -22.74 -38.54 -29.48 -29.05 -14.53 -1.37 -3.95 -5.81 -5.34 -3.41 1.10 6.97 19.70 20.29 28.59 25.33 21.50 13.18 24.38 24.60 39.85 36.22 2.26 -17.77 -6.57 -23.06 -58.22 -110.57 -242.16 -261.89 -299.70 -310.56 -274.51 -134.09 -144.01 -115.13 -78.37 -28.11 -30.10 -21.52 -13.60 -4.33 -20.20 -1.34 -1.01 - -15.87 - - - - - - - - - -

Current Ratio

1.4 1.5 1.5 1.4 1.4 1.4 1.4 1.6 1.6 1.6 1.5 1.6 1.5 1.5 1.5 1.6 1.5 1.5 1.5 1.4 1.5 1.5 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.7 1.7 1.7 1.7 2.6 2.6 2.6 2.6 2.2 2.2 2.2 2.2 0.9 0.9 - - - - - - - - - -

DSO

16.1 19.4 19.8 25.4 11.9 10.3 10.6 11.1 11.0 11.9 - 6.8 6.6 14.9 - 12.4 11.5 11.3 - 11.0 13.4 15.0 - 19.0 21.6 14.8 - 8.0 8.4 10.3 - 15.9 17.3 17.9 - 16.9 18.7 18.9 - 16.4 19.8 26.4 - 35.4 37.1 33.2 - 12.2 - - - - - - - - - -

DPO

36.3 47.8 42.9 15.7 26.5 47.1 53.0 60.5 60.0 83.5 - 36.3 37.9 70.6 - 78.3 74.2 70.2 - 83.2 104.2 94.8 - 97.6 107.2 105.1 - 105.4 108.8 109.0 - 116.2 127.2 139.7 - 133.9 132.3 188.2 - 244.4 230.1 265.8 - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - 11.0 11.9 - 6.8 6.6 14.9 - 12.4 11.5 11.3 - 11.0 13.4 15.0 - 19.0 21.6 14.8 - 8.0 8.4 10.3 - 15.9 17.3 17.9 - 16.9 18.7 18.9 - 16.4 19.8 26.4 - 35.4 37.1 33.2 - 12.2 - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - -49.0 -71.6 - -29.6 -31.3 -55.8 - -65.9 -62.7 -58.9 - -72.3 -90.8 -79.8 - -78.6 -85.6 -90.4 - -97.5 -100.4 -98.7 - -100.3 -109.9 -121.8 - -117.0 -113.5 -169.3 - -228.1 -210.3 -239.4 - 35.4 37.1 33.2 - 12.2 - - - - - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company The Joint Corp., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
- 10.96 % $ 46.2 M chinaChina
Apollo Medical Holdings Apollo Medical Holdings
AMEH
- -2.11 % $ 1.84 B usaUSA
Мать и Дитя Мать и Дитя
MDMG
- - - russiaRussia
Amedisys Amedisys
AMED
- 0.01 % $ 3.3 B usaUSA
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
- 26.45 % $ 70.6 M usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
- - $ 68.1 M usaUSA
Surgery Partners Surgery Partners
SGRY
$ 15.73 3.35 % $ 2 B usaUSA
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
- -2.09 % $ 216 M usaUSA
Sanara MedTech Sanara MedTech
SMTI
$ 25.56 0.24 % $ 220 M usaUSA
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
- -0.32 % $ 98.4 M usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
- 3.54 % $ 1.5 B usaUSA
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
$ 4.3 -0.69 % $ 564 M chinaChina
AMN Healthcare Services AMN Healthcare Services
AMN
$ 32.89 -0.54 % $ 1.27 B usaUSA
Hanger Hanger
HNGR
- - $ 732 M usaUSA
IMAC Holdings IMAC Holdings
IMAC
- -1.77 % $ 25.4 M usaUSA
LHC Group LHC Group
LHCG
- - $ 5.27 B usaUSA
American Shared Hospital Services American Shared Hospital Services
AMS
$ 1.46 2.1 % $ 9.66 M usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
- -13.87 % $ 1.52 M usaUSA
Chemed Corporation Chemed Corporation
CHE
$ 511.13 1.86 % $ 7.68 B usaUSA
MEDNAX MEDNAX
MD
$ 26.26 2.66 % $ 2.21 B usaUSA
ModivCare ModivCare
MODV
- -25.23 % $ 6.12 M usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
$ 114.55 2.35 % $ 2.07 B usaUSA
SunLink Health Systems SunLink Health Systems
SSY
- 17.98 % $ 7.81 M usaUSA
Oak Street Health Oak Street Health
OSH
- 0.03 % $ 9.53 B usaUSA
Ontrak Ontrak
OTRK
- -11.98 % $ 1.53 M usaUSA
Regional Health Properties Regional Health Properties
RHE
- - $ 5.2 M usaUSA
Tivity Health Tivity Health
TVTY
- 0.09 % $ 1.6 B usaUSA
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
$ 24.91 0.52 % $ 12.4 B usaUSA
Brookdale Senior Living Brookdale Senior Living
BKD
$ 15.15 4.48 % $ 3.56 B usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
$ 24.59 0.61 % $ 7.16 B germanyGermany
The Pennant Group The Pennant Group
PNTG
$ 41.16 3.39 % $ 1.42 B usaUSA
Encompass Health Corporation Encompass Health Corporation
EHC
$ 112.89 1.65 % $ 11.3 B usaUSA
Option Care Health Option Care Health
OPCH
$ 21.66 2.75 % $ 3.51 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
$ 22.74 1.4 % $ 1.65 B usaUSA
Community Health Systems Community Health Systems
CYH
$ 2.73 -1.8 % $ 365 M usaUSA
DaVita DaVita
DVA
$ 235.44 0.5 % $ 17.5 B usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
$ 11.26 -3.84 % $ 1.05 B britainBritain
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
- - $ 2.02 B usaUSA
National HealthCare Corporation National HealthCare Corporation
NHC
$ 225.69 2.12 % $ 3.49 B usaUSA
Universal Health Services Universal Health Services
UHS
$ 155.75 2.96 % $ 9.9 B usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
$ 34.03 -0.01 % $ 1.38 B usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
$ 74.58 2.02 % $ 1.13 B usaUSA
HCA Healthcare HCA Healthcare
HCA
$ 382.19 1.51 % $ 90.4 B usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
$ 34.51 1.47 % $ 3.13 B usaUSA
The Ensign Group The Ensign Group
ENSG
$ 172.99 3.27 % $ 9.91 B usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
$ 233.2 17.17 % $ 21 B usaUSA